Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-90
SponsorLudwig-Maximilians - University of Munich
About this trial
The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services.
The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.
Eligibility criteria
Qualifiers
Age: Participants must be 60 years or older at the time of consent.
Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study.
Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes).
Consent: Ability to provide informed consent voluntarily.
Disqualifiers
Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires.
Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology.
Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,020 Participants
are grouped into 1 trial groupSponsors and collaborators
Ludwig-Maximilians - University of Munich
Lead sponsor
Bayerisches Staatsministerium für Gesundheit, Pflege und Prävention
Collaborator
Source ClinicalTrials.gov